Drew Deniger

Insider Reports History

Location
Houston, TX
Signature
/s/ Melinda Lackey, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Drew Deniger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Alaunos Therapeutics, Inc. Vice President, Research and Development Employee Stock Option (right to buy) 125,000 15 Mar 2023 Direct

Insider Reports Filed by Drew Deniger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRT Alaunos Therapeutics, Inc. 15 Mar 2023 1 $0 4 Vice President, Research and Development 17 Mar 2023, 20:30
TCRT Alaunos Therapeutics, Inc. 15 Sep 2022 1 $0 4 VP, Research and Development 19 Sep 2022, 16:30
TCRT Alaunos Therapeutics, Inc. 29 Mar 2022 0 $0 3 VP, Research & Development 08 Apr 2022, 16:30